...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Chronic regulation of the expression of gap junction proteins connexin40, connexin43, and connexin45 in neonatal rat cardiomyocytes.
【24h】

Chronic regulation of the expression of gap junction proteins connexin40, connexin43, and connexin45 in neonatal rat cardiomyocytes.

机译:慢性调节新生大鼠心肌细胞中缝隙连接蛋白连接蛋白40,连接蛋白43和连接蛋白45的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

Gap junction channels form the basis of intercellular communication in the heart. In the working myocardium, the connexin43 (Cx43) is most abundantly found, whereas connexin40 (Cx40) is expressed in the atria and in the conduction system [together with low levels of connexin45 (Cx45)]. However, little is known about the differential regulation of the connexins by pathophysiologically stimuli such as tumor necrosis factor alpha (TNFalpha). Inasmuch as TNFalpha may play a contributory role in the concert of factors involved in the pathophysiology of heart failure and because this cardiac disease often leads to ventricular reentrant arrhythmia, the goal of our study was to find out whether TNFalpha may influence the expression of the cardiac connexins connexin43, connexin40, and connexin45. Neonatal rat cardiomyocytes were exposed to TNFalpha (10, 40, 100, 400, and 1000 pg/ml) for 24 h with or without additional treatment with the mitogenic-activated protein kinase (MAP-kinase) inhibitors SB203580 [4-(4-fluorophenyl)-2-(4-methyl-sulfinylphenyl)-5-(4-pyridyl)-1H-imidazole ; 10(-5) M, protein38 mitogenic-activated protein kinase (p38 MAP kinase) inhibitor] or the MEK1 (mitogenic-activated protein kinase/extracellular signal-regulated kinase kinase) inhibitor PD98059 [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; 10(-5) M]. Connexin43, connexin40, and connexin45 expressions were analysed using Western blot analysis, immunohistology, and polymerase chain reaction (PCR) studies (connexin43 and connexin40). TNFalpha induced a concentration-dependent increase in connexin43 (by 2.9+/-0.6, P<0.05, n=5) but not in connexin40 or connexin45 expressions. Both connexins (40 and 45) showed a very low expression near the detection limit. The increases in connexin43 expression could be completely suppressed by SB203580 (0.9+/-0.4, P<0.05, n=5) but not by PD98059. In absence of a stimulating drug, these inhibitors (SB203580 or PD98059) did not affect connexin43 content. Additional PCR experiments revealed increasesin connexin43 mRNA under the influence of 100 pg/ml TNFalpha (211+/-38%, P<0.05, n=5), which could be completely suppressed by SB203580. In contrast, the connexin40 expression remained unchanged. From these results, we conclude that TNFalpha can differentially regulate cardiac connexin expression via p38 MAP kinase pathway and thus may alter intercellular communication. This may contribute to the changes observed in heart failure with regard to the formation of an arrhythmogenic substrate.
机译:间隙连接通道形成心脏中细胞间通讯的基础。在工作心肌中,发现连接蛋白43(Cx43)最多,而连接蛋白40(Cx40)在心房和传导系统中表达[连同低水平的连接蛋白45(Cx45)]。但是,关于诸如病理学坏死因子α(TNFα)的病理生理刺激对连接蛋白的差异调节知之甚少。由于TNFalpha可能在与心力衰竭的病理生理有关的因素的协调中起重要作用,并且由于该心脏病经常导致室性折返性心律失常,因此我们的研究目标是确定TNFalpha是否会影响心脏的表达连接蛋白connexin43,connexin40和connexin45。新生大鼠心肌细胞暴露于TNFalpha(10、40、100、400和1000 pg / ml)24小时,有无丝裂原活化蛋白激酶(MAP-激酶)抑制剂SB203580 [4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑; 10(-5)M,蛋白38有丝分裂激活蛋白激酶(p38 MAP激酶)抑制剂]或MEK1(有丝分裂激活蛋白激酶/细胞外信号调节激酶激酶)抑制剂PD98059 [2-(2-氨基-3-甲氧基苯基) )-4H-1-苯并吡喃-4-酮; 10(-5)M]。使用蛋白质印迹分析,免疫组织学和聚合酶链反应(PCR)研究(connexin43和connexin40)分析了connexin43,connexin40和connexin45的表达。 TNFalpha诱导connexin43浓度依赖性增加(增加2.9 +/- 0.6,P <0.05,n = 5),但不引起connexin40或connexin45表达的增加。两种连接蛋白(40和45)在检测限附近均显示非常低的表达。连接蛋白43表达的增加可以被SB203580完全抑制(0.9 +/- 0.4,P <0.05,n = 5),而不能被PD98059抑制。在没有刺激药物的情况下,这些抑制剂(SB203580或PD98059)不影响连接蛋白43的含量。额外的PCR实验表明,在100 pg / ml TNFalpha(211 +/- 38%,P <0.05,n = 5)的影响下,连接蛋白43 mRNA的增加,可以被SB203580完全抑制。相反,连接蛋白40表达保持不变。从这些结果,我们得出结论,TNFα可以通过p38 MAP激酶途径差异调节心脏连接蛋白的表达,因此可能改变细胞间的通讯。这可能会导致心律失常方面的变化,从而导致心律失常的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号